Second-line Advanced Therapy in Crohn's Disease: Real-life Effectiveness and Resolution of First-line Suboptimal Control Indicators (CROHNOS - CROHN Therapy Observational Study)
Latest Information Update: 30 Jul 2025
At a glance
- Drugs Risankizumab (Primary) ; Upadacitinib (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- Acronyms CROHNOS
- Sponsors AbbVie
Most Recent Events
- 30 Jul 2025 New trial record